To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Other Federal Drug Control Programs for fiscal year 2024.
Impact
The potential implications of HB 2073 are multifaceted. By limiting funding to drug control programs, the bill raises questions about the federal government's ability to effectively combat drug-related issues, particularly as the nation continues to grapple with the opioid crisis and other substance abuses. Advocates for the bill argue that it will encourage a more efficient allocation of resources and force accountability among agencies responsible for drug policy. Critics, however, express concern that reducing funding could hinder ongoing initiatives and support systems, potentially exacerbating the challenges posed by drug abuse in many communities.
Summary
House Bill 2073 is designed to impose limitations on the availability of funds allocated to the Executive Office of the President, specifically targeting the Office of National Drug Control Policy and other federal drug control programs for the fiscal year 2024. The bill stipulates that the total appropriated amounts cannot exceed $118,327,000. This limitation represents a significant cut compared to previous years, aiming to direct federal spending towards other priorities while addressing concerns regarding efficacy and fiscal responsibility in drug control efforts.
Contention
The discussions surrounding HB 2073 are likely to spark debate regarding the balance between fiscal discipline and public health needs. Proponents argue that the current spending levels are unsustainable and that the bill promotes responsible budgeting without undermining the fight against drug abuse. In contrast, opponents argue that the funding cap could lead to dire consequences, with fewer resources available for treatment, prevention, and education programs that are crucial in addressing drug-related issues. This contention reflects broader ideological divides regarding the role of government in managing public health crises and managing fiscal priorities.
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Federal Drug Control Programs, High Intensity Drug Trafficking Areas Program for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Salaries and Expenses for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Official Residence of the Vice President, Operating Expenses for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, National Security Council and Homeland Security Council for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Executive Residence at the White House, White House Repair and Restoration for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Executive Residence at the White House, Operating Expenses for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Office of Administration, Salaries and Expenses for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Office of Management and Budget, Salaries and Expenses for fiscal year 2024.